171 related articles for article (PubMed ID: 30913094)
21. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
Varun BR; Ranganathan K; Rao UK; Joshua E
J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
[TBL] [Abstract][Full Text] [Related]
22. Nucleolar organiser region (NOR) distribution as a diagnostic marker in oral keratosis, dysplasia and squamous cell carcinoma.
Warnakulasuriya KA; Johnson NW
J Oral Pathol Med; 1993 Feb; 22(2):77-81. PubMed ID: 8445547
[TBL] [Abstract][Full Text] [Related]
23. Exfoliative cytology as a tool for monitoring pre-malignant and malignant lesions based on combined stains and morphometry techniques.
Gonzalez Segura I; Secchi D; Carrica A; Barello R; Arbelo D; Burgos A; Brunotto M; Zarate AM
J Oral Pathol Med; 2015 Mar; 44(3):178-84. PubMed ID: 25065639
[TBL] [Abstract][Full Text] [Related]
24. [Detection of TP53-mutations in brush biopsies from oral leukoplakias].
Scheifele C; Schlechte H; Bethke G; Reichart PA
Mund Kiefer Gesichtschir; 2002 Nov; 6(6):410-4. PubMed ID: 12447653
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical detection of human telomerase reverse transcriptase in oral cancer and pre-cancer.
Palani J; Lakshminarayanan V; Kannan R
Indian J Dent Res; 2011; 22(2):362. PubMed ID: 21891916
[TBL] [Abstract][Full Text] [Related]
26. Oral leukoplakia: A diagnostic challenge for clinicians and pathologists.
van der Waal I
Oral Dis; 2019 Jan; 25(1):348-349. PubMed ID: 30203899
[No Abstract] [Full Text] [Related]
27. Salivary Tumour Necrosis Factor-α as a Biomarker in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
G D; Nandan SRK; Kulkarni PG
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2087-2093. PubMed ID: 31350970
[TBL] [Abstract][Full Text] [Related]
28. Epithelial and fibroblast SPARC expression patterns in oral leukoplakia and oral squamous cell carcinoma.
Poomsawat S; Kosanwat T; Meesakul O; Sanguansin S
Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Aug; 134(2):e44-e50. PubMed ID: 35165061
[TBL] [Abstract][Full Text] [Related]
29. Loss of heterozygosity: a potential tool in management of oral premalignant lesions?
Zhang L; Rosin MP
J Oral Pathol Med; 2001 Oct; 30(9):513-20. PubMed ID: 11555152
[TBL] [Abstract][Full Text] [Related]
30. Expression of programmed cell death-ligand 1 in oral squamous cell carcinoma and oral leukoplakia is associated with disease progress and CD8+ tumor-infiltrating lymphocytes.
Chen XJ; Tan YQ; Zhang N; He MJ; Zhou G
Pathol Res Pract; 2019 Jun; 215(6):152418. PubMed ID: 31027907
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemistry of YAP and dNp63 and survival analysis of patients bearing precancerous lesion and oral squamous cell carcinoma.
Ono S; Nakano K; Takabatake K; Kawai H; Nagatsuka H
Int J Med Sci; 2019; 16(5):766-773. PubMed ID: 31217745
[No Abstract] [Full Text] [Related]
32. [Oral medicine 8. Leukoplakia of the oral mucosa].
Schepman KP; van der Meij EH; de Visscher JG
Ned Tijdschr Tandheelkd; 2013; 120(7-8):384-90. PubMed ID: 23923441
[TBL] [Abstract][Full Text] [Related]
33. 3p14 and 9p21 loss is a simple tool for predicting second oral malignancy at previously treated oral cancer sites.
Rosin MP; Lam WL; Poh C; Le ND; Li RJ; Zeng T; Priddy R; Zhang L
Cancer Res; 2002 Nov; 62(22):6447-50. PubMed ID: 12438233
[TBL] [Abstract][Full Text] [Related]
34. Quantification of AgNOR expression in exfoliated oral mucosal cells of tobacco chewers with and without lesion.
Sharma A; Saxena S
Indian J Dent Res; 2012; 23(2):251-6. PubMed ID: 22945719
[TBL] [Abstract][Full Text] [Related]
35. Analysis of silver binding nucleolar organizer regions in exfoliative cytology smears of potentially malignant and malignant oral lesions.
Sowmya GV; Nahar P; Astekar M; Agarwal H; Singh MP
Biotech Histochem; 2017; 92(2):115-121. PubMed ID: 28296547
[TBL] [Abstract][Full Text] [Related]
36. [Determination of human papillomavirus in oral leukoplakia,oral lichen planus and oral squamous cell carcinoma].
Cao J; Jin JQ; Deng DJ; Liu HW
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):84-8. PubMed ID: 26885914
[TBL] [Abstract][Full Text] [Related]
37. Recognition of oral potentially malignant disorders and transformation to oral cancer.
Vail M; Robinson S; Condon H
JAAPA; 2020 Nov; 33(11):14-18. PubMed ID: 33109976
[TBL] [Abstract][Full Text] [Related]
38. Oral exfoliative cytology of smokers at discrete clinical stages using AgNOR staining.
Sethi P; Shah PM
Indian J Dent Res; 2003; 14(3):142-5. PubMed ID: 15164655
[TBL] [Abstract][Full Text] [Related]
39. Noninvasive molecular screening for oral precancer in Fanconi anemia patients.
Smetsers SE; Velleuer E; Dietrich R; Wu T; Brink A; Buijze M; Deeg DJ; Soulier J; Leemans CR; Braakhuis BJ; Brakenhoff RH
Cancer Prev Res (Phila); 2015 Nov; 8(11):1102-11. PubMed ID: 26276748
[TBL] [Abstract][Full Text] [Related]
40. Significance of silver-stained nucleolar organizer regions in early diagnosis and prognosis of oral squamous cell carcinoma: a multivariate analysis.
Pillai KR; Sujathan K; Madhavan J; Abraham EK
In Vivo; 2005; 19(4):807-12. PubMed ID: 16001464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
